UAE Ministry of Health withdraws pharmaceutical products due to non-compliance
Products manufactured by Julphar
WAM (Emirates News Agency) - 08 Feb 2021
Gulf Pharmaceutical Industries P.S.C. (JULPHAR.AD)
Also known as: Julphar
1.35 AED 0.000.00%
Julphar Stock Price & Performance
Recommendation
-
Div Yield
-
P/E (Last 12 Month)
0.0
Upside
-
Target Price (Mean)
-
Open
1.35 AED
Previous Close
1.35 AED
Turnover
17.54K AED
EPS
-
Volume
12,995
Transactions
1
Market Cap
1.56B AED
IPO Date
20-Oct-2002
Analyst Estimates
| EPS | Revenue | |
|---|---|---|
| Mean Estimate |  | |
| Smart Estimate | | |
| Predicted Surprise | | |
| Mean Chg % | | |
Starmine Models
StarMine provides a suite of proprietary alpha-generating analytics and models spanning sectors, regions, and markets.
| Bullish | |
|---|---|
| Value Momentum | |
| Intrinsic Valuation | |
| Relative Valuation | |
| Credit Risk - Smart Ratios | |
| Credit Risk- Text Mining | |
| Bearish | |
|---|---|
| Price Momentum | |
About Gulf Pharmaceutical Industries P.S.C.
Business Summary
Manufacture of generic drugs, medical supplies, vitamins, cosmetics and skin care products.
Country of Incorporation
Ownership Type
Established In
1980
Primary Sector
Stock Listing
| ID | Stock Type | Currency | Exchange | Symbol |
|---|---|---|---|---|
| JULPHAR.AD | Ordinary | AED | Abu Dhabi SE | JULPHAR |
Contact details
Primary address
Building: Julphar ComplexStreet: Airport Road
Area: Digdaga Area
P.O. Box: 997
Country: UAE
City: Ras Al Khaimah
CONTACT
- Tel: +971 7-246-1461
- Tel: +971 7-204-5273
- Fax: +971 7-246-2462
- Fax: +971 7-246-1462
- Email: info@julphar.net
- www.julphar.net
Region
Ras Al KhaimahOwnership
Ownership
| Investor | Holding | No. of Shares | Last Update |
|---|---|---|---|
| | | |
| | | |
Holding Concentrations
| Investor | Holding | No. of Shares | Last Update |
|---|---|---|---|
| | | |
| | | |
Financials
Revenue
Net Income
Profit Margin
Total Assets
Total Liabilities
Debt to Assets
Operating
Investing
Financing
Executives
Dr Essam Farouk Hussein Mohammed
Chief Executive Officer
Mr Juergen Wolfgang Lauterbach
Chief Financial Officer and Chief Strategy Officer
Mr Georges Ibrahim
Chief Quality Officer
Board Members
HH Sheikh Sakr Bin Humaid Bin Abdullah Al Qassimi
Chairman
Mr Yousef Ali Mohammed Ghuloom Al Blooshi
Vice Chairman
Mr Khalid Abdullah Yousef Abdullah Al Abdullah
Director
Company information provided by Refinitiv
Refinitiv research team update company information from primary sources (company annual reports, press releases, company websites, corporate briefings, official statements/interviews) and reliable secondary sources (stock markets, reliable third party publications).
Zawya Coverage
ADNOC, Korea's GS Energy to explore opportunities to grow Abu Dhabi's hydrogen economy
Saudi Sipchem plans early redemption of $267mln of sukuk in April
UAE lender ADIB recommends dividend of 46.6% for 2020
More than 1,000 apartments, villas sold in Dubai in one week
Long-standing ADIB board member quits post
Thursday Outlook: Dollar hit seven-month high; Asian shares drop
Powell's comments at virtual Jobs Summit could set the tone for global markets
Stock Market Data
Powered By Knowledge Direct